Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem ; 18(3): 1297-311, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20061160

ABSTRACT

Chemical investigation of Indonesian marine sponges Agelas linnaei and A. nakamurai afforded 24 alkaloid derivatives representing either bromopyrrole or diterpene alkaloids. A. linnaei yielded 16 bromopyrrole alkaloids including 11 new natural products with the latter exhibiting unusual functionalities. The new compounds include the first iodinated tyramine-unit bearing pyrrole alkaloids, agelanesins A-D. These compounds exhibited cytotoxic activity against L5178Y mouse lymphoma cells with IC(50) values between 9.25 and 16.76 muM. Further new compounds include taurine acid substituted bromopyrrole alkaloids and a new dibromophakellin derivative. A. nakamurai yielded eight alkaloids among them are three new natural products. The latter include the diterpene alkaloids (-)-agelasine D and its oxime derivative and the new bromopyrrole alkaloid longamide C. (-)-Agelasine D and its oxime derivative exhibited cytotoxicity against L5178Y mouse lymphoma cells (IC(50) 4.03 and 12.5 microM, respectively). Furthermore, both agelasine derivatives inhibited settling of larvae of Balanus improvisus in an anti-fouling bioassay and proved to be toxic to the larvae. (-)-Agelasine D inhibited the growth of planktonic forms of biofilm forming bacteria S. epidermidis (MIC<0.0877 microM) but did not inhibit biofilm formation whereas the oxime derivative showed the opposite activity profile and inhibited only biofilm formation but not bacterial growth. The structures of the isolated secondary metabolites were elucidated based on extensive spectroscopic analysis involving one- and two-dimensional NMR as well as mass spectrometry and comparison with literature data.


Subject(s)
Agelas/chemistry , Alkaloids/chemistry , Alkaloids/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Cytotoxins/chemistry , Cytotoxins/pharmacology , Agelas/metabolism , Alkaloids/isolation & purification , Animals , Anti-Bacterial Agents/isolation & purification , Biofilms/drug effects , Bromine Compounds/chemistry , Bromine Compounds/isolation & purification , Bromine Compounds/pharmacology , Cell Line, Tumor , Cell Survival/drug effects , Cytotoxins/isolation & purification , Diterpenes/chemistry , Diterpenes/isolation & purification , Diterpenes/pharmacology , Indonesia , Larva/drug effects , Mice , Pyrroles/chemistry , Pyrroles/isolation & purification , Pyrroles/pharmacology , Staphylococcus epidermidis/drug effects , Thoracica/drug effects
2.
Int J Med Microbiol ; 300(2-3): 109-17, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20005777

ABSTRACT

The emergence of methicillin-resistant Staphylococcus aureus (MRSA) in animals such as horses, pet animals and productive livestock has raised questions of a probable human origin and in more general of host specificity of S. aureus. Particular clonal lineages are obviously specific for humans (e.g. ST15, ST25, ST45) and other for ruminants (e.g. ST151). MRSA associated with veterinary nosocomial infections (e.g. ST8 and ST254 in horses, ST22 in small animals) very likely have their origin in health care facilities. MRSA ST398 which became first known from widespread colonization in industrially raised pigs seems to have a limited host specificity and is able to colonize and to cause infections in various hosts. Mechanisms of host adaptation and their genomic background are poorly understood so far.


Subject(s)
Methicillin-Resistant Staphylococcus aureus/physiology , Staphylococcal Infections/veterinary , Animals , Cross Infection/microbiology , Cross Infection/transmission , Cross Infection/veterinary , Genome, Bacterial , Host-Pathogen Interactions , Humans , Species Specificity , Staphylococcal Infections/microbiology , Staphylococcal Infections/transmission , Zoonoses
SELECTION OF CITATIONS
SEARCH DETAIL
...